Hematology-Oncology Medical Group of Fresno, Inc.

Fresno, California 93720

0 studies enrolling now · 2 studies all time

What they study most

Lymphoma, Non-Hodgkin, Multiple Myeloma

Studies at this site

• A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy — Stopped early
• Pegylated Liposomal Doxorubicin, Bortezomib, Dexamethasone and Lenalidomide for Relapsed/Refractory Multiple Myeloma — Completed